PAI

A. The manufacturing facility is inspected by the FDA after an NDA, abbreviated antibiotic drug application (AADA), or ANDA is submitted and before the application is approved. B. A PAI may also be initiated if a major change is reported in a supplemental application to an NDA, AADA, or ANDA. C. During the PAI, the…